-
Huang Guo meets with WHO representative to China
2026-06-01
Huang Guo, commissioner of the National Medical Products Administration (NMPA), met on May 27 in Beijing with a delegation led by Martin Taylor, World Health Organization (WHO) representative to China.
-
Huang Guo meets with Singaporean health authority CEO
2026-05-15
Huang Guo, commissioner of the National Medical Products Administration (NMPA), met in Beijing on May 11 with a delegation led by Raymond Chua Swee Boon, chief executive officer of the Health Sciences Authority (HSA) of Singapore.
-
NMPA holds special training program on quality improvement of vaccines, blood products
2026-04-17
On April 10, the National Medical Products Administration (NMPA) convened a special public training program, with online and on-site participation, on inspection, rectification and quality improvement of vaccines and blood products in order to further reinforce oversight of the quality and safety of these medical products.
-
Yang Sheng meets with associate commissioner for global policy and strategy of US FDA
2026-02-03
On Jan 27, Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA) of China, met with a visiting delegation led by Mark Abdoo, associate commissioner for global regulatory operations and policy of the US Food and Drug Administration (FDA).
-
China revises drug administration regulations to spur innovation, tighten oversight
2026-01-28
China has revised regulations concerning drug administration in a bid to promote drug innovation, strengthen management of online sales of medicines and reinforce drug safety supervision.
-
NMPA to enhance drug regulation under revised rules — committed to a people-centered healthy policy and strengthen high-effect regulation
2026-01-08
The revised Regulation aims to further encourage drug research and innovation, strengthen the whole life-cycle control of drugs and provide a solid legal guarantee for high-level drug safety and the high-quality development of the pharmaceutical industry.
